Other: Vitamin K Cream ( DrugBank: Vitamin K )
1 disease
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 13 | Multiple sclerosis/Neuromyelitis optica | 1 |
13. Multiple sclerosis/Neuromyelitis optica
Clinical trials : 3,342 / Drugs : 2,355 - (DrugBank : 406) / Drug target genes : 269 - Drug target pathways : 241
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT03091569 (ClinicalTrials.gov) | March 10, 2017 | 21/3/2017 | Effects of Vitamin K on Redness Associated With Injection Site Reactions in Participants Treated With Plegridy | Effects of VITAmin K in Lessening Erythema Grade Associated to Injection Site Reactions in Patients Treated With PlegridY (VITALITY) | Relapsing-Remitting Multiple Sclerosis | Other: Vitamin K Cream;Other: Placebo Cream | Biogen | NULL | Completed | 18 Years | N/A | All | 23 | Phase 4 | Italy |